$ENGN news

The latest ENGN stock news: headlines, filings, AI summaries and sentiment for $ENGN, updated around the clock.

• Wall Street Analyst Updates: Nvidia Downgrades Amid Leadership Concerns and AMD Upgrade CNBC · November 12, 2026, 12:58 UTC
• enGene Therapeutics Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 11:14 UTC
• enGene Therapeutics Reports Positive Phase 2 LEGEND Trial Data for Detalimogene Seeking Alpha · November 12, 2026, 06:39 UTC
• enGene Therapeutics Inc. - 10-Q Filing SEC EDGAR · September 8, 2026, 11:44 UTC
• enGene Therapeutics Inc. - 8-K Filing SEC EDGAR · September 8, 2026, 11:44 UTC
• enGene Therapeutics Reports Q3 GAAP Loss Per Share of -$0.47, Below Estimates Seeking Alpha · September 8, 2026, 11:33 UTC
• enGene Therapeutics Inc. - 8-K Filing SEC EDGAR · July 17, 2026, 20:07 UTC
• enGene Therapeutics Inc. - 8-K Filing SEC EDGAR · July 16, 2026, 12:07 UTC
• Neumora's Depression Drug Fails Phase 3 Trials; enGene to Cut Staff by Half Yahoo Finance · June 16, 2026, 09:08 UTC
• Pomerantz Law Firm Investigates enGene Therapeutics for Potential Securities Fraud PR Newswire · June 4, 2026, 14:00 UTC
• Viridian Therapeutics (VRDN) Stock Posts Double-Digit Growth Year-on-Year Yahoo Finance · April 22, 2026, 14:17 UTC